APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Afatinib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Afatinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173961200323 December 2025176 pages

Choose your research edition.

Industry ResearchAfatinib Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Afatinib Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal Afatinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Afatinib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Afatinib Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Afatinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Afatinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Afatinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Afatinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Afatinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Afatinib include Boehringer Ingelheim, Beacon Pharma and Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Afatinib market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Afatinib and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Afatinib revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Afatinib market size, projected growth trends, production technologies, key applications, and end-use industries.

Afatinib Segment by Company

Boehringer Ingelheim

Beacon Pharma

Hengrui Medicine

Afatinib Segment by Type

50mg Tables

40mg Tables

30mg Tables

25mg Tables

20mg Tables

Others

Afatinib Segment by Application

Drug Center

Hospital

Clinic

Others

Afatinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Afatinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Afatinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Afatinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Afatinib in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Afatinib industry.

Chapter 3: Detailed analysis of Afatinib companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Afatinibrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Afatinib Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 50mg Tables Table 3. Key Players of 40mg Tables Table 4. Key Players of 30mg Tables Table 3. Key Players of 25mg Tables Table 4. Key Players of 20mg Tables Table 5. Key Players of Others Table 6. Global Afatinib Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Drug Center Table 8. Key Players of Hospital Table 9. Key Players of Clinic Table 10. Key Players of Others Table 11. Global Afatinib Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Afatinib Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Afatinib Market Share by Region (2021-2026) Table 14. Global Afatinib Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Afatinib Market Share by Region (2027-2032) Table 16. Afatinib Industry Trends Table 17. Afatinib Industry Drivers Table 18. Afatinib Industry Opportunities and Challenges Table 19. Afatinib Industry Restraints Table 20. Global Afatinib Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Afatinib Revenue Market Share by Company (2021-2026) Table 22. Global Afatinib Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Afatinib Key Company Head Office and Area Served Table 24. Global Afatinib Company, Product Type & Application Table 25. Global Afatinib Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Afatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Afatinib Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Afatinib Revenue Market Share by Type (2021-2026) Table 32. Global Afatinib Revenue Market Share by Type (2027-2032) Table 33. Global Afatinib Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Afatinib Revenue Market Share by Application (2021-2026) Table 37. Global Afatinib Revenue Market Share by Application (2027-2032) Table 38. Boehringer Ingelheim Company Information Table 39. Boehringer Ingelheim Business Overview Table 40. Boehringer Ingelheim Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Boehringer Ingelheim Afatinib Product Portfolio Table 42. Boehringer Ingelheim Recent Development Table 43. Beacon Pharma Company Information Table 44. Beacon Pharma Business Overview Table 45. Beacon Pharma Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Beacon Pharma Afatinib Product Portfolio Table 47. Beacon Pharma Recent Development Table 48. Hengrui Medicine Company Information Table 49. Hengrui Medicine Business Overview Table 50. Hengrui Medicine Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Hengrui Medicine Afatinib Product Portfolio Table 52. Hengrui Medicine Recent Development Table 53. North America Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 54. North America Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 55. North America Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 56. North America Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 57. North America Afatinib Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 58. North America Afatinib Market Size by Country (2021-2026) Table 59. North America Afatinib Market Size by Country (2027-2032) Table 60. Europe Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 61. Europe Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 62. Europe Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 63. Europe Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 64. Europe Afatinib Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. Europe Afatinib Market Size by Country (2021-2026) Table 66. Europe Afatinib Market Size by Country (2027-2032) Table 67. China Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 68. China Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 69. China Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 70. China Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 71. Asia Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 72. Asia Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 73. Asia Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 74. Asia Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 75. Asia Afatinib Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Asia Afatinib Market Size by Country (2021-2026) Table 77. Asia Afatinib Market Size by Country (2027-2032) Table 78. South America, Middle East & Africa Afatinib Market Size by Type (2021-2026) & (US$ Million) Table 79. South America, Middle East & Africa Afatinib Market Size by Type (2027-2032) & (US$ Million) Table 80. South America, Middle East & Africa Afatinib Market Size by Application (2021-2026) & (US$ Million) Table 81. South America, Middle East & Africa Afatinib Market Size by Application (2027-2032) & (US$ Million) Table 82. South America, Middle East & Africa Afatinib Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. South America, Middle East & Africa Afatinib Market Size by Country (2021-2026) Table 84. South America, Middle East & Africa Afatinib Market Size by Country (2027-2032) Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Afatinib Product Image Figure 2. Global Afatinib Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Afatinib Market Share by Type: 2025 VS 2032 Figure 4. 50mg Tables Image Figure 5. 40mg Tables Image Figure 6. 30mg Tables Image Figure 7. 25mg Tables Image Figure 8. 20mg Tables Image Figure 9. Others Image Figure 10. Global Afatinib Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Afatinib Market Share by Application: 2025 VS 2032 Figure 12. Drug Center Image Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Others Image Figure 16. Global Afatinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Afatinib Market Size (2021-2032) & (US$ Million) Figure 18. Global Afatinib Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Afatinib Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Afatinib Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Afatinib Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Afatinib Revenue Market Share by Type (2021-2032) Figure 25. Global Afatinib Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Afatinib Revenue Market Share by Application (2021-2032) Figure 27. North America Afatinib Market Size (2021-2032) & (US$ Million) Figure 28. North America Afatinib Market Share by Type (2021-2032) Figure 29. North America Afatinib Market Share by Application (2021-2032) Figure 30. North America Afatinib Market Share by Country (2021-2032) Figure 31. United States Afatinib Market Size (2021-2032) & (US$ Million) Figure 32. Canada Afatinib Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Afatinib Market Size (2021-2032) & (US$ Million) Figure 34. Europe Afatinib Market Size (2021-2032) & (US$ Million) Figure 35. Europe Afatinib Market Share by Type (2021-2032) Figure 36. Europe Afatinib Market Share by Application (2021-2032) Figure 37. Europe Afatinib Market Share by Country (2021-2032) Figure 38. Germany Afatinib Market Size (2021-2032) & (US$ Million) Figure 39. France Afatinib Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Afatinib Market Size (2021-2032) & (US$ Million) Figure 41. Italy Afatinib Market Size (2021-2032) & (US$ Million) Figure 42. Russia Afatinib Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Afatinib Market Size (2021-2032) & (US$ Million) Figure 44. China Afatinib Market Size (2021-2032) & (US$ Million) Figure 45. China Afatinib Market Share by Type (2021-2032) Figure 46. China Afatinib Market Share by Application (2021-2032) Figure 47. Asia Afatinib Market Size (2021-2032) & (US$ Million) Figure 48. Asia Afatinib Market Share by Type (2021-2032) Figure 49. Asia Afatinib Market Share by Application (2021-2032) Figure 50. Asia Afatinib Market Share by Country (2021-2032) Figure 51. Japan Afatinib Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Afatinib Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Afatinib Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Afatinib Market Size (2021-2032) & (US$ Million) Figure 55. India Afatinib Market Size (2021-2032) & (US$ Million) Figure 56. Australia Afatinib Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Afatinib Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Afatinib Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Afatinib Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Afatinib Market Share by Country (2021-2032) Figure 61. Brazil Afatinib Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Afatinib Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Afatinib Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Afatinib Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Afatinib Market Size (2021-2032) & (US$ Million) Figure 66. UAE Afatinib Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Afatinib Market Size (2021-2032) & (US$ Million) Figure 68. Chile Afatinib Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg Tables
  • 40mg Tables
  • 30mg Tables
  • 25mg Tables
  • 20mg Tables
  • Others
Applications
  • Drug Center
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boehringer Ingelheim
  • Beacon Pharma
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Afatinib Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 50mg Tables
  5. 1.2.3 40mg Tables
  6. 1.2.4 30mg Tables
  7. 1.2.5 25mg Tables
  8. 1.2.6 20mg Tables
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Afatinib Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Drug Center
  13. 1.3.3 Hospital
  14. 1.3.4 Clinic
  15. 1.3.5 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Afatinib Growth Trends by Region
  18. 1.5.1 Global Afatinib Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Afatinib Market Size by Region (2021-2026)
  20. 1.5.3 Afatinib Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Afatinib Market Dynamics
  1. 2.1 Afatinib Industry Trends
  2. 2.2 Afatinib Industry Drivers
  3. 2.3 Afatinib Industry Opportunities and Challenges
  4. 2.4 Afatinib Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Afatinib Revenue by Company (2021-2026)
  2. 3.2 Global Afatinib Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Afatinib Key Company Head office and Area Served
  4. 3.4 Global Afatinib Company, Product Type & Application
  5. 3.5 Global Afatinib Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Afatinib Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Afatinib Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Afatinib Tier 1, Tier 2, and Tier 3
4 Afatinib Market by Type
  1. 4.1 Global Afatinib Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Afatinib Market Size by Type (2021-2032)
  3. 4.3 Global Afatinib Market Size Share by Type (2021-2032)
5 Afatinib Market by Application
  1. 5.1 Global Afatinib Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Afatinib Market Size by Application (2021-2032)
  3. 5.3 Global Afatinib Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Afatinib Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Beacon Pharma
  8. 6.2.1 Beacon Pharma Company Information
  9. 6.2.2 Beacon Pharma Business Overview
  10. 6.2.3 Beacon Pharma Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Beacon Pharma Afatinib Product Portfolio
  12. 6.2.5 Beacon Pharma Recent Developments
  13. 6.3 Hengrui Medicine
  14. 6.3.1 Hengrui Medicine Company Information
  15. 6.3.2 Hengrui Medicine Business Overview
  16. 6.3.3 Hengrui Medicine Afatinib Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Hengrui Medicine Afatinib Product Portfolio
  18. 6.3.5 Hengrui Medicine Recent Developments
7 North America
  1. 7.1 North America Afatinib Market Size (2021-2032)
  2. 7.2 North America Afatinib Market Size by Type
  3. 7.2.1 North America Afatinib Market Size by Type (2021-2026)
  4. 7.2.2 North America Afatinib Market Size by Type (2027-2032)
  5. 7.2.3 North America Afatinib Market Share by Type (2021-2032)
  6. 7.3 North America Afatinib Market Size by Application
  7. 7.3.1 North America Afatinib Market Size by Application (2021-2026)
  8. 7.3.2 North America Afatinib Market Size by Application (2027-2032)
  9. 7.3.3 North America Afatinib Market Share by Application (2021-2032)
  10. 7.4 North America Afatinib Market Size by Country
  11. 7.4.1 North America Afatinib Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Afatinib Market Size by Country (2021-2026)
  13. 7.4.3 North America Afatinib Market Size by Country (2027-2032)
  14. 7.4.4 North America Afatinib Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Afatinib Market Size (2021-2032)
  2. 8.2 Europe Afatinib Market Size by Type
  3. 8.2.1 Europe Afatinib Market Size by Type (2021-2026)
  4. 8.2.2 Europe Afatinib Market Size by Type (2027-2032)
  5. 8.2.3 Europe Afatinib Market Share by Type (2021-2032)
  6. 8.3 Europe Afatinib Market Size by Application
  7. 8.3.1 Europe Afatinib Market Size by Application (2021-2026)
  8. 8.3.2 Europe Afatinib Market Size by Application (2027-2032)
  9. 8.3.3 Europe Afatinib Market Share by Application (2021-2032)
  10. 8.4 Europe Afatinib Market Size by Country
  11. 8.4.1 Europe Afatinib Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Afatinib Market Size by Country (2021-2026)
  13. 8.4.3 Europe Afatinib Market Size by Country (2027-2032)
  14. 8.4.4 Europe Afatinib Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Afatinib Market Size (2021-2032)
  2. 9.2 China Afatinib Market Size by Type
  3. 9.2.1 China Afatinib Market Size by Type (2021-2026)
  4. 9.2.2 China Afatinib Market Size by Type (2027-2032)
  5. 9.2.3 China Afatinib Market Share by Type (2021-2032)
  6. 9.3 China Afatinib Market Size by Application
  7. 9.3.1 China Afatinib Market Size by Application (2021-2026)
  8. 9.3.2 China Afatinib Market Size by Application (2027-2032)
  9. 9.3.3 China Afatinib Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Afatinib Market Size (2021-2032)
  2. 10.2 Asia Afatinib Market Size by Type
  3. 10.2.1 Asia Afatinib Market Size by Type (2021-2026)
  4. 10.2.2 Asia Afatinib Market Size by Type (2027-2032)
  5. 10.2.3 Asia Afatinib Market Share by Type (2021-2032)
  6. 10.3 Asia Afatinib Market Size by Application
  7. 10.3.1 Asia Afatinib Market Size by Application (2021-2026)
  8. 10.3.2 Asia Afatinib Market Size by Application (2027-2032)
  9. 10.3.3 Asia Afatinib Market Share by Application (2021-2032)
  10. 10.4 Asia Afatinib Market Size by Country
  11. 10.4.1 Asia Afatinib Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Afatinib Market Size by Country (2021-2026)
  13. 10.4.3 Asia Afatinib Market Size by Country (2027-2032)
  14. 10.4.4 Asia Afatinib Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Afatinib Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Afatinib Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Afatinib Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Afatinib Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Afatinib Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Afatinib Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Afatinib Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Afatinib Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Afatinib Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Afatinib Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Afatinib Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Afatinib Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Afatinib Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Afatinib Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst